This study was conducted to detect and analyse the presence of plasmid-mediated quinolone resistance (PMQR) determinants [qnr, aac(69)-Ib-cr and qepA] among Citrobacter freundii isolates from patients in Anhui province, PR China. During 2009-2010, 31 C. freundii strains were collected from various hospital units and patient specimens. Using PCR, qnr genes were detected in eight isolates, but aac(69)-Ib-cr and qepA genes were not found. The genes qnrA1, qnrB1, qnrB2, qnrB4, qnrB10 and qnrB24 were present in 6.5, 3.2, 6.5, 3.2, 3.2 and 3.2 % of C. freundii isolates, respectively. A new subgene of qnrB variant (qnrB24) was found and identified for what we believe to be the first time. PFGE after XbaI digestion of genomic DNA indicated that qnr-positive strains were not clonally related. Conjugation experiments were conducted to determine whether the qnr-carrying plasmids were self-transferable, and plasmids of transconjugants were extracted and analysed. The qnr genes were transferred from three clinical isolates to their transconjugants. Two qnrA1 genes transferred quinolone resistance with a plasmid of~11 kb, whilst the size of the plasmid carrying the qnrB4 gene was~64 kb. The susceptibility of positive isolates and transconjugants was tested using an agar dilution method according to Clinical and Laboratory Standards Institute guidelines, and the MICs of ciprofloxacin and levofloxacin were determined using Etest strips. Most isolates with qnr genes were resistant to fluoroquinolones and other antimicrobial agents. The MICs of transconjugants showed reduced susceptibility to fluoroquinolones.
INTRODUCTION
Fluoroquinolones are broad-spectrum antimicrobial agents currently effective in the treatment of a wide range of infections (Hopkins et al., 2005) . Quinolones and fluoroquinolones are used extensively in both human and veterinary medicine and are therefore found as residues in the environment. This widespread use has been associated with increased levels of quinolone resistance, particularly in the last 10 years (Robicsek et al., 2006a) . However, resistance is emerging in both production (Webber & Piddock, 2001 ) and companion (Cohn et al., 2003; Pomba et al., 2009) animals. During these years, the extensive use and misuse of fluoroquinolones has become a driver of both chromosome-encoded and plasmidencoded mechanisms of quinolone resistance (PMQR), with a potential selective advantage for PMQR determinants. PMQR determinants also play a role in the tight association between quinolone resistance and resistance to other antimicrobial agents.
PMQR genes (qnr) have been reported worldwide (Nordmann & Poirel, 2005; Wang et al., 2008) . The first qnr determinant was reported in a clinical isolate of Klebsiella pneumoniae from the USA in 1998 (Martínez-Martínez et al., 1998) . qnr genes have now been identified widely in various enterobacterial species, in both community and nosocomial settings (Robicsek et al., 2006a) . Robicsek et al. (2006b) screened 313 ceftazidime-resistant Enterobacteriaceae isolates obtained in the USA from 1999 to 2004 for all three known qnr genes. A qnr gene was present in 20 % of K. pneumoniae isolates, 31 % of Enterobacter sp. isolates and 4 % of Escherichia coli isolates. PMQR genes were significantly more prevalent in Enterobacteriaceae (Robicsek et al., 2006a; Ma et al., 2009) . Jacoby et al. (2008) found various qnr genes differing from each other by ¢40 % in nucleotide sequence, identified in different species of Enterobacteriaceae. Within each family, minor (¡10 %) variation in sequence has defined a growing number of alleles (Jacoby et al., 2008) . The Qnr proteins belong to the pentapeptide repeat family, which protects the DNA gyrase and topoisomerase IV from inhibition by quinolones. The aminoglycoside acetyltransferase variant AAC(69)-Ib-cr is capable of acetylating and subsequently reducing the activity of norfloxacin and ciprofloxacin. The recently described fluoroquinolonespecific efflux pump protein QepA is involved in pumping fluoroquinolones out of bacterial cells (Yamane et al., 2007) . In recent years, these PMQR genes have been found in various bacteria.
Citrobacter freundii, a pathogen that is increasingly frequently causing nosocomial infections, is becoming multiresistant. Park et al. (2007) found that the prevalence of qnr genes was 38.4 % in 138 C. freundii isolates, whilst Bae et al. (2010) found qnrB22 and qnrB23 genes in Citrobacter werkmanii and C. freundii. These studies found that C. freundii often has PMQR determinants and some confer resistance to multiple drugs, and that qnr genes and other determinants are widely distributed in human clinical isolates of the family Enterobacteriaceae around the world (Park et al., 2007) . The current study was thus designed to investigate the prevalence and transmission of PMQR determinants among C. freundii in Anhui province, PR China.
METHODS
Strains, plasmids and growth conditions. In total, 31 C. freundii strains were isolated from 2009 to 2010 at the First Affiliated Hospital of Anhui Medical University, PR China. The azide-resistant E. coli J53 strain (E. coli J53Az R ) was chosen as the recipient strain for conjugation experiments. Strains were routinely grown in LuriaBertani broth. Culture plates contained Mueller-Hinton agar.
Susceptibility testing. Antimicrobial susceptibility to various antibiotics was determined by agar dilution on Mueller-Hinton agar plates, according to Clinical and Laboratory Standards Institute guidelines (CLSI, 2009a, b) . Quality control for MICs was performed using the reference strain E. coli ATCC 25922. The MICs of ciprofloxacin and levofloxacin were determined using Etest strips according to the manufacturer's instructions.
PCR amplification and sequencing. All the isolates were screened for the genes qnrA, qnrB, qnrS, qnrC, qnrD, aac(69)-Ib-cr and qepA by multiplex PCRs, using the primers shown in Table 1 . Positive and negative controls were included. Positive PCR products were confirmed by sequence analysis. Sequences were analysed using the DNASTAR software package and compared with sequences deposited in GenBank.
Transfer of PMQR genes and plasmid characterization.
The mechanism of PMQR transfer from qnr-positive C. freundii isolates to E. coli J53Az R was examined by conjugation experiments (Martínez-Martínez et al., 1998) . To avoid the development of spontaneous chromosomal mutations to fluoroquinolone resistance in the recipients, transconjugants were selected on Mueller-Hinton agar plates containing ampicillin (64 mg ml
21
) with sodium azide (200 mg ml 21 ). Conjugation experiments were carried out at 37 uC. The transconjugant isolates were also screened by PCR for qnr genes. Plasmid DNA was extracted from transconjugants and subjected to electrophoresis on a 0.9 % (w/v) agarose gel with ethidium bromide at 120 V for 1 h. The size of plasmid was estimated by comparison with plasmid molecular size standards from E. coli strain V517.
PFGE. PFGE analysis of XbaI-digested (Promega) genomic DNA was performed (Gautom, 1997) . The results of PFGE were analysed according to Tenover et al. (1995) .
RESULTS AND DISCUSSION

Screening for the PMQR gene
The prevalence of qnr genes among the screened isolates was 25.8 % (8/31) in this study. qnrA1, qnrB1, qnrB2, qnrB4, qnrB10 and qnrB24 were present in 6.5, 3.2, 6.5, 3.2, 3.2 and 3.2 % of C. freundii isolates, respectively. Other PMQR genes were negative in these isolates. Sequence analysis revealed that the qnrB gene of isolate 3 had a maximal nucleotide identity of 96.7 % compared with the qnrB10 gene of C. werkmanii (GenBank accession no. EU136184). Three nucleotide changes were observed. The CAA change at nt 139 resulted in LeuAMet, CAT at nt 257 produced an AlaAVal change, and AAG at nt 670 produced an IleAVal change. Hence, we propose that qnrB is designated qnrB24, a new variant of the qnrB gene, in accordance with the qnr nomenclature rules of Jacoby et al. (2008) .
Results of PFGE
The PFGE patterns of the eight PMQR-positive isolates appeared to be different from each other, which suggested that these isolates were not clonally related.
Conjugation experiments and plasmid analysis
qnr genes were successfully transferred from three clinical isolates (isolates 4, 13 and 23) to their transconjugants. Transconjugants 4 and 13 with the qnrA1 gene harboured a single plasmid of~11 kb, whilst transconjugant 23 with the qnrB4 gene contained a plasmid of~64 kb. Among these qnr-positive isolates, qnrA genes could be transferred by conjugation to the recipient E. coli J53Az R (2/2, 100 %). In contrast, qnrB genes were transferred successfully in only one isolate for qnrB4 (1/6, 16.7 %).
Antimicrobial susceptibility testing
In addition to being resistant to quinolones, qnr-positive clinical isolates were also resistant to various antibiotics, including aminoglycosides and b-lactams. Isolates 4, 5, 7, 12, 13, 22 and 23 had a ciprofloxacin MIC of 8-64 mg ml 21 , whilst isolate 7 had a ciprofloxacin MIC of 1 mg ml
21
. The overall resistance rate of all qnr-positive isolates to ciprofloxacin was 87.5 %.
The percentages of isolates with intermediate resistance or resistance to cefotaxime, amikacin, ceftazidime, cefepime and gentamicin were 75, 37.5, 62.5, 37.5 and 87.5 %, respectively. All isolates were susceptible to imipenem (Table 2 ). All transconjugants showed reduced susceptibility to fluoroquinolones compared with the recipient E. coli J53Az R . The qnr-containing transconjugants conferred decreased susceptibility to ciprofloxacin (MIC range 0.19-1.0 mg ml
) and levofloxacin (MIC range 0.19-0.75 mg ml 21 ), representing 10-23-fold increases compared with those of the recipient, which had a ciprofloxacin MIC of 0.016 mg ml 21 and a levofloxacin MIC of 0.032 mg ml
. Some were also resistant to other antimicrobial agents. The co-transferred plasmid-mediated resistance to non-fluoroquinolone antimicrobial agents is shown in Table 2 .
This study examined the plasmid-mediated mechanisms of fluoroquinolone resistance in 31 C. freundii isolates obtained from Anhui, PR China. Our results found that the prevalence of qnr genes was 25.8 %. The qnrA gene found was qnrA1, whilst the qnrB genes comprised qnrB1, qnrB2, qnrB4, qnrB10 and qnrB24 in C. freundi. These results are consistent with conclusions in previous studies (Park et al., 2007) . In this study, we found a novel qnrB variant, qnrB24, and this is also the first report, to our knowledge, of the presence of qnrB10 in C. freundii in Anhui, PR China. We also found that the MICs of fluoroquinolones for clinical isolates were higher than those for their transconjugants. Many studies have indicated that chromosomal quinolone resistance-determining region (QRDR) mutations in gyrA and parC play an important role in mediating high-level quinolone resistance (Eaves et al., 2004) . Fang et al. (2009) found that Enterobacteriaceae harbouring qnrB4 or qnrB6 were highly resistant to all the fluoroquinolones tested. This high-level resistance was associated with multiple chromosomal substitutions in gyrA and parC. Alterations at codons Ser83 and Asp87 in GyrA and at codons Ser80 and Glu84 in ParC were observed in these isolates. In fact, some reports (Martínez-Martínez et al., 2003; Tran et al., 2005) have suggested that qnr confers only low-level resistance to quinolone and that its main contribution is to facilitate the development of QRDR mutations. The mechanism of action of the QRDR might cause various MICs of fluoroquinolone in qnr-positive isolates and transconjugants. Previous studies have also shown variable qnr expression in transconjugants, and variable promoter strengths can account for differences in MICs (Xu et al., 2007) . In this study, we found that one PMQR determinants in Citrobacter freundii isolates isolate did not confer the ciprofloxacin resistance phenotype, indicating that using quinolone or fluoroquinolone breakpoints as markers for detection might underestimate the prevalence of PMQR. This finding could have clinical implications, as qnr genes might promote further selection from low-to high-level resistance when quinolones are used. Conjugation experiments suggested the occurrence of horizontal mobility of the qnr genes. Susceptibility testing of all the transconjugants demonstrated the transfer of quinolone resistance and hence plasmid-mediated resistance determinants. The qnr genes were located in conjugative plasmids, so the genes could increase bacterial resistance to fluoroquinolones through the transmitted plasmid. As a method for studying epidemics, the PFGE results showed that these isolates were not clonally related. The plasmids carrying qnr genes varied widely in size and associated multiresistance. The transconjugant susceptibility testing results showed they were not only resistant to fluoroquinolones but also to b-lactams, aminoglycosides and other antibiotics. Genes for qnrA and sometimes qnrB have been found as part of complex sul1-type integrons containing a presumed recombinase gene, orf513 (Robicsek et al., 2006a) . The qnr gene is probably aided by its genetic linkage to resistance determinants for various other antibiotics. A similar result was found in the results of Corkill et al. (2005) . Two possible causes for the resistance change are as follows: (i) qnr-positive isolates often carry extended-spectrum blactamase or ampC genes; and (ii) the qnr gene is often located on plasmids or integrons that include the genes aac, cat, ampR, aar, dfr or aad (Li, 2005) .
In conclusion, we believe this to be the first description of plasmid-mediated fluoroquinolone resistance in C. freundii isolates from Anhui province, PR China. In this survey, qnr genes, especially qnrB, were prevalent in C. freundii isolates from Anhui province, together with resistance to various other antimicrobial agents. We also found a new variant of qnrB, qnrB24. We intend to study the function of qnrB24 and its genetic environment further in the future. 
